Impact of a multipronged approach to reduce the incidence of Clostridioides difficile infections in hospitalized patients.


Journal

American journal of infection control
ISSN: 1527-3296
Titre abrégé: Am J Infect Control
Pays: United States
ID NLM: 8004854

Informations de publication

Date de publication:
06 2023
Historique:
received: 25 05 2022
revised: 23 08 2022
accepted: 24 08 2022
medline: 23 5 2023
pubmed: 9 9 2022
entrez: 8 9 2022
Statut: ppublish

Résumé

Effective approaches to reduce Clostridioides difficile infections (CDI) in hospitalized patients are needed. We report data from 3 years preceding and 3 years following interventions that proved successful, with detailed analysis of all cases the first year after implementation. Interventions included a nursing protocol to identify cases present on admission by asking if the patient had 1 or more liquid stools in the last 24 hours, and a 2-step testing algorithm with samples positive by polymerase chain reaction (PCR) for the C. difficile toxin gene reflexing to an enzyme immunoassay (EIA) for the toxin antigen. Healthcare-associated infections due to CDI fell from ∼160 in each of the preceding 3 years to <65 in each of the subsequent 3 years (P < .001), while the ratio of observed-to-expected hospital-onset cases diminished to ∼0.50 (P < .02). In the first year, 395 samples were PCR(+), but only 118 (29.9%) of these were EIA(+). 55 (46.6%) of the PCR(+)/EIA(+) samples were from hospital day 1 or 2 and classified as present on admission. The mean time from stool collection to report of PCR results was ∼7.5 hours, and the EIA took on average only 68 additional minutes to be reported. The number of incident CDI cases can be dramatically decreased by implementing an admission screening question and a 2-step testing algorithm.

Sections du résumé

BACKGROUND
Effective approaches to reduce Clostridioides difficile infections (CDI) in hospitalized patients are needed. We report data from 3 years preceding and 3 years following interventions that proved successful, with detailed analysis of all cases the first year after implementation.
METHODS
Interventions included a nursing protocol to identify cases present on admission by asking if the patient had 1 or more liquid stools in the last 24 hours, and a 2-step testing algorithm with samples positive by polymerase chain reaction (PCR) for the C. difficile toxin gene reflexing to an enzyme immunoassay (EIA) for the toxin antigen.
RESULTS
Healthcare-associated infections due to CDI fell from ∼160 in each of the preceding 3 years to <65 in each of the subsequent 3 years (P < .001), while the ratio of observed-to-expected hospital-onset cases diminished to ∼0.50 (P < .02). In the first year, 395 samples were PCR(+), but only 118 (29.9%) of these were EIA(+). 55 (46.6%) of the PCR(+)/EIA(+) samples were from hospital day 1 or 2 and classified as present on admission. The mean time from stool collection to report of PCR results was ∼7.5 hours, and the EIA took on average only 68 additional minutes to be reported.
CONCLUSIONS
The number of incident CDI cases can be dramatically decreased by implementing an admission screening question and a 2-step testing algorithm.

Identifiants

pubmed: 36075295
pii: S0196-6553(22)00662-9
doi: 10.1016/j.ajic.2022.08.027
pii:
doi:

Substances chimiques

Bacterial Toxins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

668-674

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Michael Katzman (M)

Department of Medicine and Department of Microbiology and Immunology, Penn State College of Medicine, Milton S. Hershey Medical Center, Hershey, PA. Electronic address: mkatzman@psu.edu.

Austin C Cohrs (AC)

Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA.

Patricia E Hnatuck (PE)

Department of Quality and Infection Prevention, Milton S. Hershey Medical Center, Hershey, PA.

Wallace H Greene (WH)

Department of Clinical Pathology, Milton S. Hershey Medical Center, Hershey, PA.

Stephanie M Reed (SM)

Department of Nursing, Milton S. Hershey Medical Center, Hershey, PA.

Michael A Ward (MA)

Information Services, Penn State Health, Hershey, PA.

Frendy D Glasser (FD)

Center for Quality Innovation, Penn State Health, Hershey, PA.

Matthew F Loser (MF)

Information Services, Penn State Health, Hershey, PA.

Cory M Hale (CM)

Department of Pharmacy, Milton S. Hershey Medical Center, Hershey, PA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH